Elevated EXO1 Expression is Associated with Breast Carcinogenesis and Poor Prognosis

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2021 Feb 11

PMID 33569437

Citations 12

Authors

Jingjing Liu

Jin Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer is the most common cancer and leading cause of cancer mortality in women worldwide. Exonuclease 1 (EXO1), a protein with 5' to 3' exonuclease and RNase H activity, could be involved in mismatch repair and recombination. This study aims to investigate the prognostic value of EXO1 in breast cancer and explore the association between EXO1 expression and breast carcinogenesis.

Methods: The data of 1,215 breast cancer susceptibility gene (BRCA) samples were obtained from The Cancer Genome Atlas (TCGA). Real-time quantitative polymerase chain reaction (RT-qPCR) further verified the elevated mRNA expression level of EXO1 in human BRCA cells MDA-MB231 compared with that in human breast epithelial cells MCF-10A. EXO1 copy number was proved to be correlated with its expression level. Besides, Kaplan-Meier analysis, differentially expressed genes and function enrichment analysis were performed.

Results: Analysis of data from The Cancer Genome Atlas (TCGA) revealed that the EXO1 expression level in breast cancer tissues was significantly increased. Real-time quantitative polymerase chain reaction (RT-qPCR) supported the elevated mRNA expression level of EXO1 in human breast cancer cells MDA-MB231 compared with that in human breast epithelial cells MCF-10A. EXO1 copy number was shown to be correlated with its expression level. Kaplan-Meier analysis showed that elevated EXO1 was an indicator of poor breast cancer prognosis. Furthermore, differentially expressed genes and function enrichment analysis indicated that the cell cycle pathway and cardiac muscle contraction pathway were activated and inhibited respectively in breast cancer samples with high EXO1 expression.

Conclusions: Therefore, this study shows that elevated EXO1 expression is associated with carcinogenesis and poor prognosis in breast cancer, and might be a biomarker for breast cancer treatment.

Citing Articles

EXO1 is a key gene for lung-resident memory T cells and has diagnostic and predictive values for lung adenocarcinoma.

Li Z, Lin X, Yang Y, Tian M, Zhang L, Huang F Sci Rep. 2025; 15(1):4002.

PMID: 39893221 PMC: 11787328. DOI: 10.1038/s41598-025-88126-w.

Identification of EXO1 as a potential biomarker associated with prognosis and tumor immune microenvironment for specific human cancers.

Wang J, Liu F, Heng J, Li G Mamm Genome. 2024; 36(1):262-279.

PMID: 39718579 DOI: 10.1007/s00335-024-10092-x.

The EXO1/Polη/Polι axis as a promising target for miR-3163-mediated attenuation of cancer stem-like cells in non-small cell lung carcinoma.

Mandal T, Shukla D, Khan M, Ganesan S, Srivastava A Br J Cancer. 2024; 131(10):1668-1682.

PMID: 39369054 PMC: 11554650. DOI: 10.1038/s41416-024-02840-2.

Rare Germline Variants in DNA Repair Genes Detected in -Negative Finnish Patients with Early-Onset Breast Cancer.

Kurkilahti V, Rathinakannan V, Nynas E, Goel N, Aittomaki K, Nevanlinna H Cancers (Basel). 2024; 16(17).

PMID: 39272813 PMC: 11393874. DOI: 10.3390/cancers16172955.

Expression profiling of luminal B breast tumor in Indian women.

Ulaganathan K, Puranam K, Mukta S, Hanumanth S J Cancer Res Clin Oncol. 2023; 149(15):13645-13664.

PMID: 37516983 DOI: 10.1007/s00432-023-05195-y.

References

Luo X, Hong X, Xiong X, Zeng L, Lim C . A single nucleotide polymorphism in EXO1 gene is associated with cervical cancer susceptibility in Chinese patients. Int J Gynecol Cancer. 2011; 22(2):220-5. DOI: 10.1097/IGC.0b013e318234fd8a. View

Lee J, Lehmann B, Terrian D, Chappell W, Stivala F, Libra M . Targeting prostate cancer based on signal transduction and cell cycle pathways. Cell Cycle. 2008; 7(12):1745-62. PMC: 2593475. DOI: 10.4161/cc.7.12.6166. View

Liu J, Campen A, Huang S, Peng S, Ye X, Palakal M . Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data. BMC Med Genomics. 2008; 1:39. PMC: 2551605. DOI: 10.1186/1755-8794-1-39. View

Benson J, Jatoi I, Keisch M, Esteva F, Makris A, Jordan V . Early breast cancer. Lancet. 2009; 373(9673):1463-79. DOI: 10.1016/S0140-6736(09)60316-0. View

Evans . Overexpression of CDC25A associated with poor prognosis in breast cancer. Mol Med Today. 2000; 6(12):459. DOI: 10.1016/s1357-4310(00)01824-4. View

de Lange T . Telomere-related genome instability in cancer. Cold Spring Harb Symp Quant Biol. 2006; 70:197-204. DOI: 10.1101/sqb.2005.70.032. View

Akram M, Iqbal M, Daniyal M, Khan A . Awareness and current knowledge of breast cancer. Biol Res. 2017; 50(1):33. PMC: 5625777. DOI: 10.1186/s40659-017-0140-9. View

Melchor L, Benitez J . An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes. Carcinogenesis. 2008; 29(8):1475-82. DOI: 10.1093/carcin/bgn157. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

10.

Chen X, Kim I, Honaker Y, Paudyal S, Koh W, Sparks M . 14-3-3 proteins restrain the Exo1 nuclease to prevent overresection. J Biol Chem. 2015; 290(19):12300-12. PMC: 4424361. DOI: 10.1074/jbc.M115.644005. View

11.

Wang H, Chiu C, Tsai R, Kuo Y, Chen H, Wang R . Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan. Anticancer Res. 2009; 29(10):3897-901. View

12.

Schaetzlein S, Chahwan R, Avdievich E, Roa S, Wei K, Eoff R . Mammalian Exo1 encodes both structural and catalytic functions that play distinct roles in essential biological processes. Proc Natl Acad Sci U S A. 2013; 110(27):E2470-9. PMC: 3704034. DOI: 10.1073/pnas.1308512110. View

13.

Zhang J, Zhou H, Zhang X, Mu W, Hu J, Liu G . Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling. BMC Cancer. 2020; 20(1):32. PMC: 6958789. DOI: 10.1186/s12885-019-6501-8. View

14.

Keijzers G, Bakula D, Petr M, Madsen N, Teklu A, Mkrtchyan G . Human Exonuclease 1 (EXO1) Regulatory Functions in DNA Replication with Putative Roles in Cancer. Int J Mol Sci. 2018; 20(1). PMC: 6337416. DOI: 10.3390/ijms20010074. View

15.

Sun X, Zheng L, Shen B . Functional alterations of human exonuclease 1 mutants identified in atypical hereditary nonpolyposis colorectal cancer syndrome. Cancer Res. 2002; 62(21):6026-30. View

16.

Bolderson E, Tomimatsu N, Richard D, Boucher D, Kumar R, Pandita T . Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaks. Nucleic Acids Res. 2009; 38(6):1821-31. PMC: 2847229. DOI: 10.1093/nar/gkp1164. View

17.

Zhou J, Wang Y, Wang Y, Yin X, He Y, Chen L . FOXM1 modulates cisplatin sensitivity by regulating EXO1 in ovarian cancer. PLoS One. 2014; 9(5):e96989. PMC: 4019642. DOI: 10.1371/journal.pone.0096989. View

18.

Luo F, Wang Y, Lin D, Li J, Yang K . Exonuclease 1 expression is associated with clinical progression, metastasis, and survival prognosis of prostate cancer. J Cell Biochem. 2019; 120(7):11383-11389. DOI: 10.1002/jcb.28415. View

19.

Keijzers G, Liu D, Rasmussen L . Exonuclease 1 and its versatile roles in DNA repair. Crit Rev Biochem Mol Biol. 2016; 51(6):440-451. DOI: 10.1080/10409238.2016.1215407. View

20.

De Sousa J, Torrieri R, Serafim R, Di Cristofaro L, Escanfella F, Ribeiro R . Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients. Tumour Biol. 2017; 39(4):1010428317694552. DOI: 10.1177/1010428317694552. View